• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Annals of Long Term Care

  • Follow us on

Search

  • Home
  • ARCHIVES
    • Issues
    • Supplements/Webcasts
  • About Us
    • Mission Statement
    • Editorial Description
    • Editorial Board
    • Publishing Staff
    • Our Partners
    • AGS Affiliations
    • Reprints/Permissions
  • SUBMIT
    • Author Guidelines
    • Copyright Transfer Form
    • Author Disclosure Form
    • Submit Now
  • CONTACT
  • ADVERTISING
    • Print Rate Card
    • Online Rate Card
    • Classified Rate Card
    • Sales Contacts
  • Supplements/Special Projects
  • Journal News
  • WEBCASTS
    • Facing Postherpetic Neuralgia in LTC
    • Treatment for Postherpetic Neuralgia Pain
    • Case Study—LTC Patient Suffering from PHN

Age-Related Eye Disease and Medication Safety

  • Thu, 6/11/09 - 11:27am
  • 0 Comments
  • 4543 reads
Citation: 

Pages 17 - 22

Author(s): 

Janice L. Feinberg, PharmD, JD, Priscilla A. Rogers, PhD, and Debra Sokol-McKay, MS, OTR/L, SCLV, CDE,
CVRT, CLVT

The leading cause of vision impairment and blindness in the United States is age-related eye disease, including age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma. There are many medication safety issues associated with vision loss. Access to prescription information, including medication labels and usage instructions, is essential for the correct taking of medication. However, many people with vision loss are unable to access important instructions for use and safety information; determine the color, shape, and markings distinguishing a medication; or see markings on measuring or testing devices. Most older people who lose their vision due to age-related eye disease are not aware of services that can help them cope with vision loss, or techniques and devices that can make medication-taking and activities of daily living easier and safer. Clinicians can direct these patients to resources designed to help enhance patient function and medication safety. (Annals of Long-Term Care: Clinical Care and Aging 2009;17[6]:17-22)

Introduction

According to the 2006 National Health Interview Survey (NHIS), of the more than 20 million Americans who reported vision loss, 6.2 million of them are age 65 years and older.1 In addition, there are approximately 9 million Americans age 45-64 who reported that they have trouble seeing, even with glasses or contacts, or that they are blind or unable to see at all.1 As the millions of baby boomers continue to age, the number of older persons with vision loss will continue to grow substantially.

The leading cause of vision impairment and blindness in the United States is age-related eye disease, including age-related macular degeneration (AMD), cataract, diabetic retinopathy, and glaucoma.2 The number of Americans with age-related eye disease and the vision impairment that results is expected to double within the next three decades.2 In addition to age-related eye diseases, physiologic changes in vision that occur with age—loss of near focus, reduced contrast sensitivity, and visual field impairment—contribute to vision impairment.

The Aging Eye

The most common age-related visual change is a decrease in the ability of the eyes to focus for close-up work (presbyopia). Other visual changes in the aging eye include a need for increased lighting, impaired color discrimination, and decreased contrast sensitivity (difficulty discerning an object against a similarly colored background). Most older adults need three to four times more light (particularly task lighting) than they previously did to perform certain types of everyday tasks. However, vision loss is not a normal part of aging.

When vision changes cannot be fully corrected to the normal range with ordinary eyeglasses, contact lenses, medication, or surgery, the result is permanently impaired vision, or low vision. Low vision refers to a range of vision capabilities and is common in older adults.

Ocular changes caused by aging are further compounded by eye disease. The four most prevalent eye conditions or diseases are diabetic retinopathy, glaucoma, cataract, and AMD. Increased age is a risk factor for cataract, diabetic retinopathy, and macular degeneration. Persons with diabetes also have a greater incidence of cataract and glaucoma. Consequently, many older adults have multiple, overlapping eye conditions.

A complete review of the pathophysiology, diagnosis, and treatment of age-related eye disease is beyond the scope of this article.

Diabetic Retinopathy

Diabetic retinopathy occurs in 4.4 million Americans age 40 years and older,2 or approximately 25% of the 17.9 million Americans diagnosed with diabetes.3 It can be present even though no subjective signs of vision loss are experienced by the individual having the condition.

References: 

1. Pleis JR, Lethbridge-Çejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2006. National Center for Health Statistics. Vital Health Stat 10 2007;(235):1-153.

2. Vision problems in the U.S. Prevalence of adult vision impairment and age-related eye disease in America. 2008 Update to 4th ed. Prevent Blindness America Website. http://www.preventblindness.org/vpus/. Accessed April 6, 2009.

3. All about Diabetes. American Diabetes Association Website. http://www.diabetes.org/about-diabetes.jsp. Accessed April 6, 2009.

4. Social Security Act. 42 U.S.C. 1382c, Sec. 1614. Meaning of terms. http://www.ssa.gov/OP_Home/ssact/title16b/1614.htm. Accessed April 6, 2009.

5. Visual impairment, visual disability and legal blindness. American Academy of Ophthalmology Website. http://www.medem.com/medlib/article/ZZZTPA3ZVIE. Accessed April 6, 2009.

6. Key definitions of statistical terms. American Foundation for the Blind Website. September 2008. http://www.afb.org/Section.asp?SectionID=15&DocumentID=1280. Accessed April 6, 2009.

7. Moisan J, Gaudet M, Grégoire JP, Bouchard R. Non-compliance with drug treatment and reading difficulties with regard to prescription labeling among seniors. Gerontology 2002;48:44-51.

8. Zuccollo G, Liddell H. The elderly and the medication label: Doing it better. Age Ageing 1985;14(6):371-376.

9. Watanabe RK, Gilbreath K, Sakamoto CC. The ability of the geriatric population to read labels on over-the-counter medication containers [published correction appears in J Am Optom Assoc 1994;65(8):551]. J Am Optom Assoc 1994;65(1):32-37.

10. Cramer JA. Enhancing patient compliance in the elderly. Role of packaging aids and monitoring. Drugs Aging 1998;12(1):7-15.

11. Cohen MR, ed. Medication Errors: Causes, Prevention, and Risk Management. Sudbury, MA: Jones and Bartlett Publishers; 2000.

12. Wogalter MS, Vigilante WJ Jr. Effects of label format on knowledge acquisition and perceived readability by younger and older adults. Ergonomics 2003;46(4):327-344.

13. Drummond SR, Drummond RS, Dutton GN. Visual acuity and the ability of the visually impaired to read medication instructions. Br J Ophthalmol 2004;88:1541-1542.

14. Key findings: National Poll on severe vision loss/blindness, 2007. American Foundation for the Blind Website. http://www.afb.org/seniorsite.asp?SectionID=68&TopicID=320&DocumentID=3376. Accessed April 6, 2009.

15. Access to Drug Labels Survey Report, 2008. American Foundation for the Blind Website. http://www.afb.org/Section.asp?SectionID=3&TopicID=135&DocumentID=4520. Accessed April 6, 2009.

16. Report to the WHCOA Policy Committee, March 12, 2005. American Foundation for the Blind Website. http://www.afb.org/Section.asp?SectionID=44&TopicID=188&DocumentID=2744. Accessed April 6, 2009.

17. Guidelines for Prescription Labeling and Consumer Medication Information for Persons with Vision Loss. American Society of Consultant Pharmacists Foundation Website.2008. http://www.ascpfoundation.org. Accessed April 6, 2009.

18. Sokol-McKay D, Michels D. The accessible pantry: Food identification tips, tools, and techniques. RE:view 2006;38(3/Fall):131-141.

19. Massof RW, Dagnelie G, Deremeik J, et al. Low vision rehabilitation in the U.S. healthcare system. J Vis Rehabil 1995;9:3-31.

image description image description
  • 1
  • 2
  • 3
  • 4
  • 5
  • next ›
  • last »



Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

LATEST NEWS

  • FDA Finally Approves Once-Weekly Type 2 Diabetes Treatment
    [Amylin] 1-31-12
  • FDA approves Voraxaze to treat patients with toxic methotrexate levels
    [FDA] 1-17-12
  • FDA approves first generic version of cholesterol-lowering drug Lipitor
    [FDA] 11-30-11
  • AHRQ Awards $34 Million To Expand Fight Against Healthcare-Associated Infections
    [AHRQ] 11-17-11
more »

Poll

Are nutritional supplements underutilized in long-term care?:

Classified/Recruitment Opportunities

  • Advertise Your Job Here
more »

ALTC Blogs

How to Create Collegiality in a Difference of Opinion: Part 1

Neil Baum MD
2/3/12 | 0 Comments | 12 reads

Dutasteride vs Low Grade Prostate Cancer

Alvin B Lin MD FAAFP
1/31/12 | 0 Comments | 37 reads

Finding “Dr. Right” For Your Practice

Neil Baum MD
1/30/12 | 0 Comments | 40 reads
more »
banner banner banner banner banner
HMP Communications © 2012 HMP Communications
  • Home
  • About Us
  • Other Publications
  • Contact Us
  • Privacy Policy

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. © 2012 HMP Communications